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Abstract
Rapid fibrovascularization is a prerequisite for successful biomaterial engraftment. In addi-
tion to their well-known roles in fibrinolysis, urokinase-type plasminogen activator (uPA)
and tissue plasminogen activator (tPA) or their inhibitor plasminogen activator inhibitor-1
(PAI-1) have recently been implicated as individual mediators in non-fibrinolytic processes,
including cell adhesion, migration, and proliferation. Since these events are critical for
fibrovascularization of biomaterial, we hypothesized that the components of the plasmino-
gen activation system contribute to biomaterial engraftment. Employing in vivo and ex vivo
microscopy techniques, vessel and collagen network formation within porous polyethylene
(PPE) implants engrafted into dorsal skinfold chambers were found to be significantly im-
paired in uPA-, tPA-, or PAI-1-deficient mice. Consequently, the force required for mechani-
cal disintegration of the implants out of the host tissue was significantly lower in the mutant
mice than in wild-type controls. Conversely, surface coating with recombinant uPA, tPA,
non-catalytic uPA, or PAI-1, but not with non-catalytic tPA, accelerated implant vasculariza-
tion in wild-type mice. Thus, uPA, tPA, and PAI-1 contribute to the fibrovascularization of
PPE implants through common and distinct effects. As clinical perspective, surface coating
with recombinant uPA, tPA, or PAI-1 might provide a novel strategy for accelerating the vas-
cularization of this biomaterial.
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Introduction
In reconstructive medicine, biomaterials are used for the augmentation or replacement of tis-
sues [1]. If autologous transplant materials are not sufficiently available, reconstructive options
for bone and cartilage tissue defects include the use of porous polyethylene biomaterial (PPE)
implants [1]. PPE implants are available for numerous applications ranging from orbital floor
reconstruction [2] over auricular reconstruction [3] to facial contour implants [4]. This im-
plant material has proofed to be biocompatible, long-term stable, non-soluble, and non-
resorbable over a period of more than 30 years of clinical use [5–7]. However, there are applica-
tions which are less favorable for implant integration, such as rhinoplasty and reconstructive
nose surgery [8] as well as reconstructions in irradiated or scar tissue, where blood supply is
weak [9].
A ‘moderate’ inflammatory response upon implantation, which induces only transient and
limited changes in microvascular permeability and alterations in leukocyte-endothelial cell
interactions, as well as the rapid formation of a dense vessel and collagen network within the
implant are considered to be prerequisites for successful biomaterial engraftment [10,11].
Interference with or delay of these events promote implant infection and dislocation, which ul-
timately might result in implant rejection [10,11].
Fibrinolysis is a fundamental biological process, which maintains tissue perfusion by pre-
venting clot formation in blood vessels [12,13]. Plasmin is the key enzyme in the fibrinolytic
system, which mediates the dissolution of fibrin polymers [14,15]. Its zymogen plasminogen is
activated by tissue plasminogen activator (tPA) [16] and–to a lesser degree–by urokinase-type
plasminogen activator (uPA) [13,17]. The activity of these serine proteases is tightly controlled
by plasminogen activator inhibitor-1 (PAI-1) [18]. These components of the plasminogen
activation system are expressed by a variety of cell types, including endothelial cells [19–21]. In
addition to their well-known roles in fibrinolysis, uPA, tPA, and PAI-1 are increasingly recog-
nized as individual mediators in non-fibrinolytic processes, such as cell adhesion, migration,
and proliferation [22–30]. Since these events are critical for the fibrovascularization of bioma-
terial, we hypothesized that the plasminogen activation system is involved in the biointegration
of PPE implants.
In the present study, we demonstrate that endogenously released uPA, tPA, and PAI-1
contribute to the functional biointegration of PPE implants via common and distinct
effects: Whereas tPA predominantly facilitates the initial vessel sprouting into PPE biomate-
rial, uPA additionally exhibits sustained effects on vascularization of these implants. Interest-
ingly, PAI-1, which serves as the principal inhibitor of tPA and uPA in fibrinolysis, supports
vascularization of PPE biomaterial differentially at various time points after implantation.
Moreover, the major components of the plasminogen activation system were found to be
critically involved in collagen deposition within PPE biomaterial thereby promoting mechan-
ical tissue integration of the implants. Notably, uPA, tPA, and PAI-1 exhibited strong che-
motactic effects on endothelial cells. Accordingly, surface coating with recombinant uPA
(mainly via its non-proteolytic properties) and–to a lesser degree–with tPA (mainly via its
proteolytic properties) or PAI-1 accelerated vascularization of PPE implants. Our experi-
mental findings provide novel insights into the mechanisms underlying tissue integration of
biomaterials and propose surface coating with recombinant uPA, tPA, or PAI-1 as a novel
promising strategy for accelerating the vascularization of PPE implants under
unfavorable conditions.
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Materials and Methods
Animals
All animal experiments were performed according to German legislation for the protection of
animals and approved by the Regierung von Oberbayern, München, Germany. Protocols were
approved under permit 55.2-1-54-2531-115-10.
Female C57BL/6J mice were purchased from Charles River (Sulzfeld, Germany). Female
uPA-/-, tPA-/-, and PAI-1-/- mice were generated as described previously and backcrossed on
the C57BL/6J background for 10 generations [31,32]. All experiments were performed with
mice at the age of 8–16 weeks. Animals were housed in single cages and had free access to tap
water and standard laboratory food (ssniff, Spezialdiaeten GmbH, Soest, Germany) throughout
the experiments.
Dorsal skinfold chamber model
The surgical preparation of the dorsal skinfold chamber was performed as described previously
[11,33]. Briefly, two symmetrical titanium frames were implanted on the extended dorsal skin-
fold thereby sandwiching the double layer of the shaved and depilated skin. Subsequently, one
layer of skin–consisting of epithelial skin layer, subcutaneous tissue, and striated skin muscle–
was completely removed in a circular area of about 15 mm in diameter and the remaining
contralateral layers are covered with a removable coverslip incorporated into the observation
window of the titanium frame. All surgical procedures were performed under anesthesia with
ketamine (75 mg/kg b.w. i.p., Ketavet; Parke-Davis, Berlin, Germany) and xylazine (25 mg/kg b.
w. i.p., Rompun; Bayer, Leverkusen, Germany). After surgery, animals were allowed to recover
for a period of 48 hours from anesthesia and microsurgery. Only chamber preparations fulfilling
the criteria of microscopically intact microcirculation and no signs of inflammation were
included in the experiments. For the implantation of the PPE material, the coverslip of the skin-
fold chamber was temporarily removed and the PPE material was implanted into the striated
skin muscle. The chambers were well tolerated and the animals showed no signs of discomfort,
as indicated by normal feeding and sleeping habits. At the end of the experiment, animals were
euthanized by an intraperitoneal injection of pentobarbital (Narcoren, Merial, Germany).
Preparation of PPE implants
Porous polyethylene sheets (PPE; Medpor; PorexSurgical, Newnan, GA; pore size 100–250 μm)
were cut into 3.0 x 3.0 x 0.1 mm slices and subsequently steam sterilized. Before implantation,
the PPE material was either bathed in sterile 0.9% saline solution or coated as described
previously [34] using 50 μL growth factor reduced (GFR) BDMatrigel Matrix (Becton Dickinson,
Heidelberg, Germany) or GFR BDMatrigel Matrix supplemented with 1 μg of recombinant
murine uPA, diisopropyl fluorophosphate (DFP)-uPA, tPA, non-enzymatic (NE)-tPA, or PAI-1
(Molecular Innovations, Novi, MI). Liquid GFR BDMatrigel entered the PPEmaterial
thoroughly at 4°C and was allowed to polymerize for 1h at 37°C before implantation.
In vivo fluorescence microscopy
For in vivo fluorescence microscopy, the awake chamber-bearing mice were immobilized in a
Perspex tube on a custom-made stage (Effenberger, Munich, Germany) under a modified Zeiss
microscope (Axiotech Vario; Zeiss, Göttingen, Germany). Fluorescein isothiocyanate (FITC)-
labeled dextran (Sigma, Deisenhofen, Germany; MW 500,000; 0.05–0.1 mL of a 5% solution in
0.9% saline) was used to enhance the contrast of the vascular network and rhodamine 6G (Mo-
lecular Probes, Eugene, OR; 0.04 mL of a 0.05% solution in 0.9% saline) was used to visualize
uPA, tPA, and PAI-1 Promote Biomaterial Engraftment
PLOS ONE | DOI:10.1371/journal.pone.0116883 February 6, 2015 3 / 18
leukocyte-endothelial cell interactions. The fluorescent dyes were administered via tail vein in-
jection. Selective observation of FITC-labeled plasma and rhodamine 6G-labeled leukocytes
was possible using epi-illumination with a 100 Wmercury lamp with selective filter blocks
(Zeiss, Göttingen, Germany).
Microcirculatory analysis
In each experiment, 9 regions of interest (ROI) were selected following a given scheme: 1 ROI
in the center of the implant, 1 ROI in each corner of the rectangular implant and 4 ROIs in the
surrounding host tissue. These ROIs were examined on day 7, 10, and 14 after biomaterial im-
plantation. In vivo fluorescence microscopy images were acquired by a charge-coupled device
(CCD) camera (Sony XC-77CE; Sony, Cologne, Germany) and recorded on digital tapes (Sony
DVCAMDSV 45P; Sony, Cologne, Germany) for subsequent off-line analysis (Cap Image;
Zeintl, Heidelberg, Germany). Parameters for offline analysis included absolute and functional
vessel density, vessel diameters, and blood flow velocities. Furthermore, skeletonized maps of
the vessel network were analyzed using the ImageJ plugin ‘Analyze Skeleton’, quantifying num-
bers of vessel junctions, numbers of vessel branches, and average branch lengths. Leukocyte-
endothelial cell interactions were characterized as numbers of rolling (< 50% of red blood cell
velocity) cells crossing a given line in 30 sec and firmly adherent (for> 30 sec) cells on 100 μm
of vessel wall.
Dynamic breaking strength
Mechanical integration of the implant material into the host tissue was assessed on day 14 after
implantation by measuring the force required for mechanical removal of the implant out of the
host tissue using a newton meter as described previously [34].
Collagen deposition
Collagen deposition within the pores of the implant was analyzed using multi-photon micros-
copy of fixed tissue samples (TriMScope, LaVision BioTec, Bielefeld, Germany) as described
elsewhere [35]. Images were aquired using an XLUMPlanFl 20 x/0.95 W objective. Excitation
wavelength was 1275 nm, with a laser intensity of 20 mW. The second harmonic (SHG) signal
was detected using a 624/40 filter. Optical sections (500 μm x 500 μm, 1450 px) were scanned
at 4 μm distances using the same settings for all samples analyzed. Z- stacks covering 100 μm
were projected and further processed using ImageJ software. The second harmonic generation
(SHG) signal was measured in 3 ROIs within the pores of each implant and normalized to the
background signal.
Confocal microscopy
Implants were fixed with 4% paraformaldehyde, permeabilized with 0.02% Triton X-100
(Merck, Darmstadt, Germany) and blocked with 1% BSA for 24 hours at 4°C. Subsequently im-
plants were incubated with primary antibodies against uPA, tPA, PAI-1 (Santa Cruz, Dallas,
TX), and CD31 for 72 hours at 4°C. Secondary antibodies (Alexa Fluor 488 goat anti-rat IgG,
Alexa Fluor 680 goat anti-rat IgG; Invitrogen, Carlsbad, CA) were incubated for 72 hours at
4°C. Images were obtained using a SP8 SMD confocal microscope (Leica, Wetzlar, Germany)
and a 63 x HC PL APO 1.2 NA water objective.
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Cell migration
Chemotaxis experiments were performed in a chemotaxis slide (Ibidi, Martinsried, Germany).
Microscopy was performed at 37°C and 5% CO2 on an inverted microscope Eclipse Ti (Nikon,
Duesseldorf, Germany), a 4 x objective and a CCD camera. Images were obtained over a total
time of 20 hours every ten minutes.
HUVECs (Human umbilical vein endothelial cells from Promocell, Heidelberg, Germany)
were cultured in growth medium (ECGM, Promocell, Heidelberg, Germany) containing 10%
fetal calf serum. After reaching confluency, cells were trypsinised, embedded into 30% Matrigel
(Corning, Amsterdam, Netherlands), diluted with basal medium (ECBM, Promocell, Heidel-
berg, Germany) and finally filled into the chemotaxis chambers at a density of 3 x 106 cells/mL.
ECGM was used as attractant-free medium, while ECGM supplemented with 30 ng/mL recom-
binant human tPA, 20 ng/mL uPA, or 1 μg/mL PAI-1 (Sino Biological, Beijing, China) was
used to analyze the chemotactic effect of these proteins on migration of HUVECs.
Cell tracking was performed using ImageJ software (National Institutes of Health, Bethesda,
USA) plugin “Manual Tracking”. 30 cells per experiment were tracked and each experiment
was repeated independently three times. For further analysis and evaluation of chemotactical
processes “Chemotaxis and Migration Tool” (ibidi, Martinsried, Germany) was used.
Experimental protocol
In a first set of experiments, PPE implants were engrafted into dorsal skinfold chambers in
wild-type (WT), uPA-/-, tPA-/-, and PAI-1-/- mice (n = 6 per group). In a second set of experi-
ments, implants coated with Matrigel as well as with Matrigel supplemented with murine uPA,
DFP-uPA, tPA, NE-tPA, or PAI-1 were implanted into dorsal skinfold chambers in WT mice
(n = 5 or 6 per group).
In vivo fluorescence microscopy was performed on days 7, 10, and 14 after implantation.
Mice were sacrificed via terminal injection of 200 mg/kg pentobarbital, and immediately after-
wards the measurement of the dynamic breaking strength was performed.
Statistical analysis
Data analysis was performed with a statistical software package (SigmaStat for Windows,
Jandel Scientific, Erkrath, Germany). The ANOVA on ranks test followed by the Dunnett test
was used for the estimation of stochastic probability in intergroup comparisons. Mean values
and SEM are given. P values< 0.05 were considered significant.
Results
Expression of uPA, tPA, and PAI-1 in PPE implants
Since plasmin(ogen) has previously been implicated in tissue integration of biomaterial [36],
we hypothesized that components of the plasminogen activation system are also involved in
the biointegration of these implants. Using immunostaining and confocal microscopy, expres-
sion of uPA, tPA, and PAI-1 was detected in CD31+ microvascular endothelial cells as well as
in and around the newly formed microvessels within the implant (Fig. 1A).
Role of uPA, tPA, and PAI-1 for vascularization of PPE implants
Rapid vascularization of PPE biomaterial is a prerequisite for its successful tissue integration
[10,11]. To evaluate the functional relevance of uPA, tPA, and PAI-1 for vascularization of
PPE implants, vascularization of this biomaterial was analyzed on days 7, 10, and 14 after im-
plantation into dorsal skinfold chambers in WT, uPA-/-, tPA-/-, or PAI-1-/- mice by in vivo
uPA, tPA, and PAI-1 Promote Biomaterial Engraftment
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fluorescence microscopy. In WT animals, initial vessel formations within the PPE implants,
which were only partially perfused, were found on day 7 after implantation. On day 10 after
implantation, a further densification of the vessel network was observed, whereas on day 14
after implantation, a complete network of perfused vessels was established in the PPE implants
(Fig. 1B). Whereas in tPA-deficient animals absolute (Fig. 1C; representing the entire vessel
network including perfused and non-perfused vessels) and functional (Fig. 1D; representing
only the network of perfused vessels) vessel density were significantly reduced in the initial
phase of biomaterial engraftment, PAI-1-deficient animals exhibited a significant defect in ab-
solute vessel density at day 10 and in functional vessel density at days 10 and 14 after implanta-
tion. In uPA-deficient animals, however, absolute and functional vessel density of PPE
implants were significantly diminished during the entire experimental period as compared to
WT controls.
In order to assess the role of uPA, tPA, and PAI-1 for vascularization of PPE implants in
more detail, a comprehensive analysis of the architecture of the newly formed vessel network
Figure 1. Role of endogenous uPA, tPA, and PAI-1 for vascularization of PPE biomaterial. The
distribution of uPA, tPA, and PAI-1 in engrafted PPE biomaterial was analyzed ex vivo in implants fromWT
mice by confocal microscopy (A; scale bar: 100 μm). Vascularization of PPE implants was analyzed in WT as
well as in uPA-, tPA-, or PAI-1-deficient mice by in vivo fluorescence microscopy. Representative in vivo
microscopy images of PPE biomaterial vascularization in aWTmouse are shown (B; scale bar: 100 μm).
Panels show results for the absolute (C) and functional (D) vessel density within the implant (mean ± SEM for
n = 6; * p< 0.05 vs. WT).
doi:10.1371/journal.pone.0116883.g001
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was performed (Fig. 2A). In the early engraftment phase, a significant reduction in both
numbers of vessel branches (Fig. 2B) and vessel junctions (Fig. 2C) was detected in uPA-/- or
tPA-/- animals as compared to WT animals. In addition, numbers of triple junctions (Fig. 2D;
representing 3 joining vessels) or quadruple junctions (Fig. 2E; representing 4 joining vessels)
were significantly reduced in the mutant animals as compared to WT controls. Whereas num-
bers of vessel branches and junctions were significantly diminished in uPA-deficient animals
as compared to WT controls at days 10 and 14 after PPE implantation, these parameters re-
mained unaltered in tPA-deficient animals during this late time period. PAI-1-deficient ani-
mals exhibited only a transient significant defect in the formation of vessel branches and
junctions at day 10 after implantation, whereas numbers of triple and quadruple vessel network
junctions were significantly lower at days 7 and 10 after implantation as compared to WT
animals. Noteworthy, the average vessel branch length remained constant over time in all ex-
perimental groups (data not shown).
Moreover, the vessel density in the host tissue surrounding the implant material was
constant during the entire observation phase and did not differ among experimental groups
(A Table in S1 File). Furthermore, no significant differences among experimental groups were
observed in average diameters, blood flow velocities, and shear rates in microvessels within the
implant material and the surrounding tissue at all time points (B Table in S1 File).
Figure 2. Role of endogenous uPA, tPA, and PAI-1 for vessel network formation in PPE biomaterial. A
detailed analysis of the vessel network within the PPE implants in WT as well as in uPA-, tPA-, or PAI-1-
deficient mice was performed by software-assisted skeletonizing of the vessel network. Representative
images of this analysis in a WTmouse are shown (A; scale bar: 100 μm). Panels show results for the number
of branches (B) and total junctions (C) as well as triple (D) and quadruple (E) junctions in the vessel network
(mean ± SEM for n = 6; * p< 0.05 vs. WT).
doi:10.1371/journal.pone.0116883.g002
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Role of uPA, tPA, and PAI-1 for leukocyte-endothelial cell interactions in
PPE implants
Leukocyte recruitment is thought to play a critical role in the engraftment of PPE biomaterial
[11]. Using in vivo fluorescence microscopy, interactions of fluorescence-labeled leukocytes
with endothelial cells were analyzed in the newly formed microvasculature within the PPE
implants (Fig. 3A). Upon biomaterial implantation, the number of leukocyte-endothelial cell
interactions in newly formed microvessels of the implant was low. Whereas in the early en-
graftment phase the number of intravascularly rolling leukocytes was significantly diminished
in microvessels of implants in uPA-/-, tPA-/-, or PAI-1-/- animals (Fig. 3B), the number of firmly
adherent leukocytes remained unchanged (Fig. 3C).
No significant differences in leukocyte-endothelial cell interactions were observed in the mi-
crovasculature of the host tissue surrounding the implant material (A Table in S1 File).
Role of uPA, tPA, and PAI-1 for mechanical tissue integration of PPE
implants
As a measure of functional tissue integration of PPE implants, the disintegration force required
for the mechanical removal of the implant out of the host tissue was assessed at the end of each
experiment on day 14 after implantation. In our experiments, the required disintegration force
was significantly lower in uPA-/-, tPA-/-, or PAI-1-/- animals as compared to WT control ani-
mals (Fig. 4A).
Mechanical tissue integration of PPE biomaterial is established through the formation of a
tight collagen network within the implant that is connected to the surrounding tissue. As a
measure of collagen deposition within the implant material, the second harmonic signal
(visualizing collagen) was analyzed by using multi-photon microscopy (Fig. 4B). In our
Figure 3. Role of endogenous uPA, tPA, and PAI-1 for leukocyte-endothelial cell interactions in PPE
biomaterial. Interactions of fluorescence-labeled leukocytes and endothelial cells in newly formed
microvessels within the PPE implants in WT as well as in uPA-, tPA-, or PAI-1-deficient mice were analyzed
by in vivo fluorescence microscopy. Representative in vivomicroscopy images of these processes in a WT
mouse are shown (A; scale bar: 100 μm). Panels show results for the number of intravascularly rolling (B)
and adherent (C) leukocytes (mean ± SEM for n = 6; * p< 0.05 vs. WT).
doi:10.1371/journal.pone.0116883.g003
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experiments, the second harmonic signal in implants from uPA-/-, tPA-/-, or PAI-1-/- animals
was significantly lower than in WT controls (Fig. 4C).
Chemotactic effect of recombinant uPA, tPA, and PAI-1 on
microvascular endothelial cells
Since uPA-, tPA-, and PAI-1-deficiency was associated with reduced vascularization of PPE
biomaterial, we hypothesized that these effects are due to the ability of the different compo-
nents of the plasminogen activation system to recruit endothelial cells. As a measure of the che-
motactic effect of uPA, tPA, or PAI-1 on endothelial cells, the forward migration index (FMI)
for migrating endothelial cells was determined in an in vitro assay (Fig. 5A). Upon exposure to
uPA, tPA, or PAI-1, the FMI for migrating endothelial cells was significantly higher than in
control experiments (Fig. 5B).
Effect of surface coating with recombinant uPA, tPA, or PAI-1 on tissue
integration of PPE implants
To translate our in vitro results in a clinically more relevant situation, PPE biomaterial was
coated with recombinant murine uPA, tPA, or PAI-1 embedded in Matrigel and implanted
into dorsal skinfold chambers of WT mice. Surface coating with uPA and–to a lesser degree–
with tPA or PAI-1 resulted in increased absolute (Fig. 6A) and functional (Fig. 6B) vessel
Figure 4. Role of endogenous uPA, tPA, and PAI-1 for mechanical tissue integration of PPE
biomaterial. Panel (A) shows results for the disintegration force (mean ± SEM for n = 6; * p< 0.05 vs. WT).
The disintegration force required for mechanical removal of the implant out of the host tissue was determined
in WT as well as in uPA-, tPA-, or PAI-1-deficient mice. Collagen deposition within the PPE biomaterial was
analyzed ex vivo in implants fromWT as well as from uPA-, tPA-, or PAI-1-deficient mice by second harmonic
imaging microscopy. A representative image from aWTmouse is shown (B; scale bar: 100 μm; red dotted
lines delineate pores of the implant material, in which collagen (white) is deposited). Panel (C) shows
quantitative results for the second harmonic signal (mean ± SEM for n = 4; * p< 0.05 vs. WT).
doi:10.1371/journal.pone.0116883.g004
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density in PPE implants in the early engraftment phase as compared to Matrigel-coated
control implants.
A more detailed analysis revealed that surface coating of PPE implants with recombinant
uPA, tPA, or PAI-1 resulted in a significant elevation in numbers of vessel branches (Fig. 6C)
and vessel junctions in the vessel network of PPE implants (Fig. 6D) as compared to control
implants. No significant differences were observed in vessel diameters, blood flow velocities,
and shear rates among experimental groups (C Table in S1 File). Furthermore, surface coating
with recombinant uPA, tPA, or PAI-1 had no effect on leukocyte-endothelial cell interactions
in microvessels within the implant material (C Table in S1 File) or the surrounding host tissue
(D Table in S1 File). Moreover, the vessel density of the surrounding host tissue remained
comparable during the entire observation period among experimental groups (D Table in
S1 File). Similarly, mechanical tissue integration of the implant material remained unaltered
upon surface coating with recombinant uPA, tPA, or PAI-1 (E Table in S1 File).
Effect of surface coating with non-catalytically active uPA or tPA proteins
on vascularization of PPE implants
To characterize the functional relevance of the catalytic properties of uPA and tPA for early
vascularization of PPE biomaterial, implants were coated with DFP-uPA (in which the catalytic
activity of uPA is inhibited by diisopropyl fluorophosphate (DFP)) or NE-tPA (which repre-
sents a tPA mutant protein completely lacking its catalytic activity) proteins. Surface coating
with DFP-uPA resulted in a significant increase in the absolute (Fig. 7A) and functional
(Fig. 7B) vessel density in the implant material as compared to control implants. This increase
was comparable to implants coated with catalytically active uPA during the early integration
phase. In contrast, surface coating with NE-tPA barely enhanced the absolute or functional ves-
sel density in PPE biomaterial. Noteworthy, biomaterial coating with NE-tPA can therefore
also be considered as an additional negative control in our experiments.
As confirmed before by zymography, there was no proteolytic activity of DFP-uPA detect-
able (data not shown; [37]).
Discussion
Rapid fibrovascularization is a prerequisite for successful engraftment of biomaterials [10, 11].
In addition to their well-known roles in fibrinolysis, the plasminogen activators uPA and tPA
as well as their inhibitor PAI-1 are increasingly recognized as individual and autonomous me-
diators in non-fibrinolytic processes, including cell adhesion, migration, and proliferation [22–
30]. Since these events are critical for the fibrovascularization of biomaterial [10, 11], we hy-
pothesized that the components of the plasminogen activation system contribute to the func-
tional biointegration of PPE implants.
In a first approach, immunostaining and confocal microscopy were used to evaluate wheth-
er the major components of the plasminogen activation system are present in engrafted PPE
implants. Here, we show that uPA, tPA, and PAI-1 are expressed by microvascular endothelial
cells and deposited in and around the newly formed microvessels within the implant. These ob-
servations complement previous reports documenting that uPA, tPA, and PAI-1 are synthe-
sized by cultured endothelial cells [19–21].
Figure 5. Effect of uPA, tPA, and PAI-1 onmigration of endothelial cells. The effect of recombinant uPA, tPA, and PAI-1 on migration of endothelial cells
was analyzed in vitro. Representative migration plots are shown (A). Panels show results for the forward migration index (FMI) of migrating endothelial cells
upon exposure to recombinant uPA, tPA, or PAI-1 (B; mean ± SEM for n = 3; * p< 0.05 vs. +/-).
doi:10.1371/journal.pone.0116883.g005
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The rapid establishment of a reliable vessel network within implanted biomaterial is strictly
required for the survival of oxygen dependent structures as well as for the prevention of im-
plant infection and rejection [38,39]. To analyze the functional relevance of the plasminogen
activation system for the vascularization of PPE biomaterial, in vivo epi-fluorescence microsco-
py was employed in implants engrafted in dorsal skinfold chambers of WT and appropriate
mutant mice. Our data indicate that the major components of the plasminogen activation sys-
tem selectively, but differentially support the vascularization process of this biomaterial with-
out effects on the existing microvasculature of the surrounding host tissue: Whereas tPA is
Figure 6. Effect of surface coating of implants with recombinant uPA, tPA, or PAI-1 on vascularization of PPE biomaterial. Vascularization of PPE
implants, which were coated with recombinant uPA, tPA, or PAI-1 embedded in Matrigel, was analyzed by in vivo fluorescence microscopy in WTmice.
Panels show results for the relative increase in absolute (A) and functional (B) vessel density within the implant as well as for the increase in the number of
branches (C) and junctions (D) in the vessel network as compared to Matrigel-coated control implants (mean ± SEM for n = 5 – 6).
doi:10.1371/journal.pone.0116883.g006
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predominantly involved in the initial stages of microvessel network formation within PPE im-
plants, uPA additionally exhibits sustained effects on vascularization of this biomaterial. Note-
worthy, PAI-1 which serves as the principal inhibitor of the plasminogen activators in
fibrinolysis, promotes the formation of the vessel network within the implant differentially at
various stages of PPE implant integration. Our results extend previous observations implicat-
ing uPA [23], tPA [40], and PAI-1 [41] in vasculo-/angiogenesis.
Taking a closer look on the architecture of the developing vessel network within the im-
plant, we found that uPA, tPA, and PAI-1 predominantly facilitate branch formation, but not
length extension of single vessel segments in the growing network suggesting that these endog-
enously released proteins are particularly involved in the maturation of the vessel network
within the biomaterial. This is an interesting finding which might be related to non-fibrinolytic
properties of these proteins that have been identified to promote proliferation of endothelial
cells [42–44].
In addition to its non-fibrinolytic effects on endothelial cells, uPA, tPA, and PAI-1 have
been reported to contribute to the regulation of leukocyte recruitment under severe inflamma-
tory conditions including ischemia-reperfusion injury [37,45–47] or sepsis [48]. Upon bioma-
terial implantation, however, only a ‘moderate’ inflammatory response arises which might
explain that deficiency of the major components of the plasminogen activation system did not
substantially alter leukocyte-endothelial cell interactions within the implant or in the sur-
rounding host tissue in our experiments.
Along with the vascularization of PPE implants, fibroblasts invade the pores of this biomate-
rial and secrete collagen. This leads to the formation of a dense collagen network that ultimate-
ly ties the implant to the surrounding host tissue. Using second harmonic generation multi-
photon microscopy, we were able to demonstrate that the major components of the plasmino-
gen activation system are critically involved in the development of this collagen network. In
this context, uPA, tPA, and PAI-1 are thought to induce proliferation of fibroblasts and stimu-
late collagen production [28–30]. Accordingly, the force needed for mechanical removal of the
implant out of the host tissue was significantly reduced in uPA-, tPA-, or PAI-1-deficient ani-
mals. Thus, our experimental data reveal that the major components of the plasminogen acti-
vation system play a crucial role for the tissue integration of PPE implants through common
and distinct effects on fibrovascularization of this biomaterial.
Figure 7. Effect of surface coating of implants with DFP-uPA or NE-tPA on vascularization of PPE
biomaterial. Vascularization of PPE implants, which were coated with DFP-uPA or NE-tPA embedded in
Matrigel, was analyzed by in vivo fluorescence microscopy in WTmice. Panels show results for the relative
increase in absolute (A) and functional (B) vessel density within the implant as compared to Matrigel-coated
control implants (mean ± SEM for n = 5 – 6).
doi:10.1371/journal.pone.0116883.g007
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Despite its excellent biocompatibility, there are applications which are less favorable for
PPE implant integration, such as rhinoplasty and reconstructive nose surgery [8] as well as re-
constructions in irradiated or scar tissue [9], where blood supply is weak. Previous attempts to
improve tissue integration of biomaterials included coating of implants with autologous mate-
rial, such as chondrocytes [10,49], adipocytes [50], adipose tissue derived microvascular frag-
ments [51], or acellular dermis [52] as well as with specific growth factors, e. g. basic fibroblast
growth factor [bFGF; [53–55]] or vascular endothelial growth factor [VEGF; [34]]. Less specif-
ic, but already in clinical use, PPE coated with oxidized cellulose polymers and the patient’s
blood (which contains uPA, tPA, and PAI-1) is successfully employed in reconstructive nose
surgery [56,57]. Together with our actual findings on the role of the plasminogen activation
system for the engraftment of PPE implants, we consequently hypothesized that surface coat-
ing with recombinant uPA, tPA, or PAI-1 supports the tissue integration of this biomaterial. In
a separate set of in vitro experiments, we found that uPA, tPA, and PAI-1 potently attract en-
dothelial cells. These results are in line with recent observations involving the plasminogen ac-
tivation system in VEGF (vascular endothelial growth factor)-dependent vessel growth which
represents one of the most prominent pathways in angiogenesis [27]. To translate these results
into a clinically more relevant context, PPE implants were embedded in Matrigel supplemented
with components of the plasminogen activation system and engrafted in dorsal skinfold cham-
bers of WT mice (Fig. 6). Surface coating with recombinant uPA, tPA, or PAI-1 lead to an ac-
celerated vascularization of PPE implants predominantly in the initial engraftment phase.
Whereas tPA particularly improved initial implant vascularization (as compared to uPA or
PAI-1), surface coating with recombinant PAI-1 still showed beneficial effects on vessel net-
work formation within the implant at late stages of the engraftment process. Notably, surface
coating with recombinant uPA exhibited the most striking effect on initial implant vasculariza-
tion (as compared to tPA or PAI-1) that persisted (at lower levels) over the entire
experimental period.
In recent studies, the plasminogen activators have been supposed to mediate their non-fibri-
nolytic properties via catalytic and non-catalytic effects [24–27,36]. Towards a more mechanis-
tic understanding of these uPA- and tPA-dependent engraftment processes, we coated PPE
implants with modified tPA or uPA proteins lacking their catalytic activity. Our experimental
data indicate that tPA promotes the vascularization of PPE implants mainly via its proteolytic
properties, whereas uPA predominantly employs its non-proteolytic properties to support
vessel network formation in this biomaterial. Since plasmin has previously been implicated in
tissue integration of biomaterial implants [36], our data suggest that the reported effect of
plasmin on biomaterial engraftment is predominantly mediated via tPA-dependent
proteolytical activation of plasminogen. In this context it is interesting that tPA-dependent
activation of plasminogen has recently been found to contribute to biological processes differ-
ent from vessel network formation including leukocyte recruitment to inflamed tissue [47].
In contrast to our findings on vascularization of PPE implants, however, surface coating
with components of the plasminogen activation system did not further enhance collagen
deposition and subsequent mechanical tissue integration of this biomaterial in our experi-
ments. These observations might be explained by the already outstanding engraftment
properties of PPE in densely vascularized and healthy host tissue. Under unfavorable implant
conditions, however, surface coating with components of the plasminogen activation system
might provide a novel, tailor-made strategy for the acceleration of biomaterial vascularization
at different stages of the engraftment process which might prevent implant infection
and rejection.
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Conclusions
Collectively, our experimental data demonstrate that endogenously released uPA, tPA, and
PAI-1 contribute to the functional biointegration of PPE implants via common and distinct ef-
fects on implant fibrovascularization: Whereas tPA predominantly facilitates the initial vessel
network formation in PPE biomaterial, uPA additionally exhibits sustained effects on vascular-
ization of these implants. Notably, PAI-1, which serves as the principal inhibitor of tPA and
uPA in fibrinolysis, supports vascularization of PPE biomaterial differentially at various stages
of the engraftment process. Furthermore, the major components of the plasminogen activation
system were found to be crucially involved in collagen deposition within PPE biomaterial
thereby promoting mechanical tissue integration of the implants. Interestingly enough, uPA,
tPA, and PAI-1 exhibited strong chemotactic effects on endothelial cells. Accordingly, surface
coating with recombinant uPA (mainly via its non-proteolytic properties) and–to a lesser de-
gree–with tPA (mainly via its proteolytic properties) or PAI-1 accelerated vascularization of
PPE implants. Our experimental findings provide novel insights into the mechanisms underly-
ing tissue integration of biomaterials and propose surface coating with recombinant uPA, tPA,
or PAI-1 as a novel promising strategy for accelerating the vascularization of PPE implants
under unfavorable conditions.
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